Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts.
Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts.
Cancer Res. 2022 Jul 5;82(13):2403-2416. doi: 10.1158/0008-5472.CAN-21-2352.
Differential expression of PKM1 and PKM2 impacts prostate tumorigenesis and suggests a potential therapeutic vulnerability in prostate cancer.
PKM1 和 PKM2 的差异表达影响前列腺肿瘤的发生,并提示前列腺癌潜在的治疗弱点。